Romanian Journal of Military Medicine,
Год журнала:
2024,
Номер
128(1), С. 51 - 59
Опубликована: Дек. 9, 2024
The
study
aims
to
assess
the
frequency
of
ESKAPE
pathogens
and
their
antimicrobial
resistance
profile
during
COVID-19
pandemic
in
a
multidisciplinary
hospital.
Based
on
microbiological
reports,
present
retrospectively
evaluated
(AMR)
microorganisms
2020-2022
hospital
Romania.
There
were
reported
1117
bacterial
isolates
account
for
33.5%
strains.
specific
AMR
cumulates
30.9%,
while
multidrug
characterizes
21%
all
K.
Pneumoniae,
followed
by
S.
aureus,
P.
aeruginosa
are
alarming
surveillance.
most
frequent
antibiotic
reports
identified
urology
department.
local
data
we
suggest
first-line
recommendations
when
suspected.
directions
near
future
stewardship
program
focus
revising
clinical
protocols
diagnosis
treatment
each
department,
increasing
bacteriological
samples
collection,
improving
diagnostic
techniques
identification,
intensifying
epidemiological
actions
surveillance,
control,
education.
Viruses,
Год журнала:
2023,
Номер
15(9), С. 1843 - 1843
Опубликована: Авг. 30, 2023
Antibacterial
resistance
is
a
renewed
public
health
plague
in
modern
times,
and
the
COVID-19
pandemic
has
rekindled
this
problem.
Changes
antibiotic
prescribing
behavior,
misinformation,
financial
hardship,
environmental
impact,
governance
gaps
have
generally
enhanced
misuse
improper
access
to
antibiotics
during
pandemic.
These
determinants,
intersected
with
antibacterial
current
pandemic,
may
amplify
potential
for
future
The
occurrence
of
infections
multidrug-resistant
(MDR),
extensively
drug-resistant
(XDR),
difficult-to-treat
(DTR),
carbapenem-resistant
(CR),
pan-drug-resistant
(PDR)
bacteria
still
increasing.
aim
review
highlight
state
art
worldwide,
focusing
on
most
important
pathogens,
namely
Enterobacterales,
Acinetobacter
baumannii,
Klebsiella
pneumoniae,
their
common
antibiotics.
Antibiotics,
Год журнала:
2025,
Номер
14(1), С. 63 - 63
Опубликована: Янв. 9, 2025
Multidrug
antimicrobial
resistance
(AMR)
represents
a
formidable
challenge
in
the
therapy
of
infectious
diseases,
triggered
by
particularly
concerning
gram-negative
Enterococcus
faecium,
Staphylococcus
aureus,
Klebsiella
pneumoniae,
Acinetobacter
baumannii,
Pseudomonas
aeruginosa,
and
Enterobacter
spp.
(ESKAPE)
pathogens.
Designated
as
"priority"
2017,
these
bacteria
continue
to
pose
significant
threat
2024,
during
worldwide
SARS-CoV-2
pandemic,
where
coinfections
with
ESKAPE
members
contributed
worsened
patient
outcomes.
The
declining
effectiveness
current
treatments
against
pathogens
has
led
an
increased
disease
burden
increase
mortality
rates
globally.
This
review
explores
sophisticated
mechanisms
driving
AMR
bacteria,
focusing
on
Key
bacterial
contributing
include
limitations
drug
uptake,
production
antibiotic-degrading
enzymes,
alterations
target
sites,
enhanced
efflux
systems.
Comprehending
pathways
is
vital
for
formulating
innovative
therapeutic
strategies
tackling
ongoing
posed
resistant
Pathogens,
Год журнала:
2024,
Номер
13(1), С. 50 - 50
Опубликована: Янв. 4, 2024
The
interruption
of
bacteriological
surveillance
due
to
the
COVID-19
pandemic
brought
serious
consequences,
such
as
collapse
health
systems
and
possible
increase
in
antimicrobial
resistance.
Therefore,
it
is
necessary
know
rate
resistance
its
associated
mechanisms
bacteria
causing
hospital
infections
during
pandemic.
aim
this
work
was
show
phenotypic
molecular
characteristics
ESKAPE
a
Mexican
tertiary
care
second
third
years
For
purpose,
2021
2022,
two
hundred
unduplicated
strains
group
(Escherichia
coli,
Klebsiella
pneumoniae,
Pseudomonas
aeruginosa,
Acinetobacter
baumannii)
were
collected
from
various
clinical
sources
categorized
by
according
CLSI.
An
analysis
variance
(ANOVA)
complemented
Tukey
test
performed
search
for
changes
susceptibility
profiles
study
period.
Finally,
involved
carbapenem
analyzed,
efflux
pumps
high-risk
sequence
types
A.
baumannii
multilocus
(MLST).
results
showed
no
K.
pneumoniae
period
analyzed.
Decreases
quinolone
identified
E.
coli
(p
=
0.039)
P.
aeruginosa
0.03).
Interestingly,
increases
penicillins
0.004),
aminoglycosides
<
0.001,
p
0.027),
carbapenems
folate
inhibitors
0.001).
Several
genes
(blaNDM,
blaVIM,
blaOXA,
blaKPC,
blaOXA-40,
blaOXA-48)
with
predominance
blaOXA-40
adeABCRS
pump
baumannii.
MLST
revealed
presence
globally
distributed
(ST369
ST758)
related
outbreaks
other
parts
world.
presented
demonstrate
that
has
played
an
important
role
nosocomial
antibiotic-resistant
pathogens
particular
MDR
potential
reservoir
genes.
implications
mainly
are
analyzed
discussed.
Pharmaceuticals,
Год журнала:
2025,
Номер
18(2), С. 161 - 161
Опубликована: Янв. 25, 2025
Background/Objectives:
Ventilator-associated
pneumonia
(VAP)
remains
a
critical
challenge
in
ICU
settings,
often
driven
by
the
biofilm-mediated
bacterial
colonization
of
endotracheal
tubes
(ETTs).
This
study
investigates
antimicrobial
resistance
patterns
and
biofilm
dynamics
patients,
focusing
on
microbial
trends
tracheal
aspirates
tube
biofilms
at
county
emergency
hospital
Romania.
Methods:
We
conducted
longitudinal
analysis
patients
requiring
mechanical
ventilation
for
more
than
48
h.
Tracheal
ETT
were
collected
three
key
time
points:
T1
(baseline),
T2
(48
h
post-intubation
with
replacement),
T3
(92–100
post-T2);
these
analyzed
using
sonication
microbiological
techniques
to
assess
patterns.
Results:
In
total
30
bacteria
from
ESKAPEE
group
(e.g.,
Klebsiella
pneumoniae,
Acinetobacter
baumannii,
Staphylococcus
aureus)
dominated
microbiota,
increasing
their
prevalence
over
time.
Resistance
carbapenems,
colistin,
vancomycin
was
notably
observed,
particularly
among
K.
pneumoniae
A.
baumannii.
Biofilm
revealed
high
persistence
rates
emergence
multidrug-resistant
strains,
underscoring
role
ETTs
as
reservoirs
resistant
pathogens.
The
replacement
correlated
shift
composition
reduced
biofilm-associated
contamination.
Conclusions:
highlights
temporal
evolution
limited
number
(30
patients).
findings
support
implementing
routine
management
strategies,
including
scheduled
replacements
advanced
biofilm-disruption
techniques,
mitigate
VAP
risk
improve
patient
outcomes.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Фев. 6, 2025
Some
studies
suggest
that
the
respiratory
microbiome
of
COVID-19
patients
differs
from
healthy
individuals,
infected
may
have
reduced
diversity
and
increased
levels
opportunistic
bacteria,
however,
role
in
fatal
SARS-CoV-2
infection
remains
poorly
understood.
Our
study
aimed
to
determine
whether
there
are
differences
between
who
recovered
those
died,
by
characterizing
bacterial
communities
both
groups.
A
total
24
died
were
included
study,
patient
data
analyzed
for
signs,
symptoms
clinical
variables.
Airway
samples
collected
16
S
rRNA
variable
regions
V3-V4
amplified
sequenced
using
Illumina
MiSeq
platform.
Elevated
blood
urea
nitrogen,
creatinine
lactate
dehydrogenase,
higher
frequencies
cardiovascular
disease,
diabetes
mellitus
renal
disease
observed
with
a
outcome.
Compared
COVID-19,
exhibited
enriched
periodontal
pathogenic
bacteria
such
as
Klebsiella
pneumoniae.
results
highlighted
dual
relationship
SARS
CoV-2
an
exacerbated
periodontopathogen-induced
immune
response.
Antibiotics,
Год журнала:
2025,
Номер
14(2), С. 186 - 186
Опубликована: Фев. 12, 2025
Antimicrobial
resistance
(AMR)
is
an
escalating
global
health
threat,
projected
to
cause
over
40
million
deaths
by
2050.
ESKAPE
pathogens
(Enterococcus
faecium,
Staphylococcus
aureus,
Klebsiella
pneumoniae,
Acinetobacter
baumannii,
Pseudomonas
aeruginosa,
and
Enterobacter
spp.)
are
major
contributors
nosocomial
infections
AMR.
We
evaluated
the
epidemiology
AMR
prevalence
of
at
University
Hospital
in
Palermo
between
January
2018
July
2023,
analyzing
factors
associated
with
mortality
patients
positive
blood
cultures.
Microbiological
data
from
all
specimen
types
were
collected
using
Business
Intelligence
system
Biwer,
excluding
duplicates.
assessed
trends
isolates
time.
Clinical
hospital
discharge
forms
used
evaluate
ESKAPE-positive
Differences
non-blood
examined.
A
total
11,607
specimens
4916
analyzed.
Most
admitted
Internal
Medicine
(19.4%),
ICU
(13.2%),
General
Surgery
(9.9%).
Additionally,
21.5%
ICU-admitted
patients.
Blood
cultures
accounted
for
14.3%
specimens,
urine
25.3%,
respiratory
secretions
22.1%,
skin
mucosal
swabs
20.9%.
The
increased
progressively,
peaking
2021.
vancomycin-resistant
E.
faecium
was
19.4%,
a
significant
upward
trend,
while
oxacillin-resistant
S.
aureus
35.0%,
showing
decline.
A.
baumannii
exhibited
high
antibiotics
tested
except
colistin
cefiderocol.
Carbapenemase
55.0%
K.
20.4%
P.
4.6%
spp.
aeruginosa
showed
decrease
meropenem
resistance.
pneumoniae
bloodstream
linked
higher
risk.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Июнь 7, 2024
Drug
repurposing
(repositioning)
is
a
dynamically-developing
area
in
the
search
for
effective
therapy
of
infectious
diseases.
Repositioning
existing
drugs
with
well-known
pharmacological
and
toxicological
profile
an
attractive
method
quickly
discovering
new
therapeutic
indications.
The
off-label
use
diseases
requires
much
less
capital
time,
can
hasten
progress
development
antimicrobial
drugs,
including
antibiotics.
drug
repositioning
searching
options
has
brought
promising
results
many
viral
diseases,
such
as
Ebola,
ZIKA,
Dengue,
HCV.
This
review
describes
most
favorable
repositioned
treatment
bacterial
infections.
It
comprises
publications
from
various
databases
PubMed
Web
Science
published
2015
to
2023.
following
keywords/strings
were
used:
and/or
antibacterial
activity
Treatment
infections
caused
by
multidrug-resistant
bacteria
taken
into
account,
methicillin-resistant
staphylococci,
Mycobacterium
tuberculosis
,
or
carbapenem-resistant
Enterobacteriaceae
family.
analyses
safety
profiles
included
their
synergistic
combinations
antibiotics
discusses
potential
antiparasitic,
anticancer,
antipsychotic
effects,
those
used
metabolic
may
be
response
public
health
threats
related
spread
strains
growing
antibiotic
resistance
microorganisms.
ESKAPE
pathogens
are
multidrug-resistant
bacteria
that
pose
a
significant
threat
to
public
health.
The
early
and
accurate
detection
of
these
is
critical
for
effective
treatment
infection
control.
Standard
microbiological
techniques,
including
staining,
morphological
cultural
characterization,
biochemical
analysis,
serotyping,
widely
used
detect
identify
pathogens.
Staining
techniques
such
as
Gram
staining
provide
valuable
information
on
the
cell
wall
structure
differentiate
between
gram-positive
gram-negative
bacteria.
Morphological
characteristics
colony
morphology
growth
requirements
can
clues
regarding
identity
Biochemical
properties
ability
ferment
specific
sugars
produce
certain
enzymes
further
help
Serotyping
involves
identification
surface
antigens
bacterial
cells
highly
sensitive
method
identifying
strains.
This
technique
particularly
useful
tracking
spread
infections
develop
targeted
vaccines.
Therefore,
standard
detecting
These
structure,
requirements,
metabolic
important
species.
Applying
in
combination
with
advanced
molecular
methods,
essential
timely
diagnosis
pathogen
infections.
Antibiotics,
Год журнала:
2024,
Номер
13(2), С. 193 - 193
Опубликована: Фев. 17, 2024
Infections
caused
by
multidrug-resistant
bacterial
and
fungal
pathogens
represent
a
significant
global
health
concern,
contributing
to
increased
morbidity
mortality
rates.
Therefore,
it
is
crucial
develop
novel
compounds
targeting
drug-resistant
microbial
strains.
Herein,
we
report
the
synthesis
of
amino
acid
derivatives
bearing
an
incorporated
4-hydroxyphenyl
moiety
with
various
substitutions.
The
resultant
3-((4-hydroxyphenyl)amino)propanoic
2–37
exhibited
structure-dependent
antimicrobial
activity
against
both
ESKAPE
group
bacteria
Candida
species.
Furthermore,
these
demonstrated
substantial
auris,
minimum
inhibitory
concentrations
ranging
from
0.5
64
µg/mL.
Hydrazones
14–16,
containing
heterocyclic
substituents,
showed
most
potent
broad-spectrum
activity.
This
extended
methicillin-resistant
Staphylococcus
aureus
(MRSA)
MIC
values
1
8
µg/mL,
vancomycin-resistant
Enterococcus
faecalis
(0.5–2
µg/mL),
Gram-negative
(MIC
8–64
species
including
auris.
Collectively,
findings
underscore
potential
utility
scaffold
for
further
development
as
foundational
platform
agents
emerging
pathogens.